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Vitamin D receptor (VDR) plays an essential role in
gastrointestinal inflammation. Most investigations
have focused on the immune response; however,
how bacteria regulate VDR and how VDR modulates
the nuclear factor (NF)-B pathway in intestinal epi-
thelial cells remain unexplored. This study investi-
gated the effects of VDR ablation on NF-B activation
in intestinal epithelia and the role of enteric bacteria
on VDR expression. We found that VDR/ mice ex-
hibited a pro-inflammatory bias. After Salmonella in-
fection, VDR/ mice had increased bacterial burden
and mortality. Serum interleukin-6 in noninfected
VDR/ mice was undetectable, but was easily detect-
able in VDR/ mice. NF-B p65 formed a complex
with VDR in noninfected wild-type mouse intestine.
In contrast, deletion of VDR abolished VDR/P65 bind-
ing. P65 nuclear translocation occurred in colonic
epithelial cells of untreated VDR/ mice. VDR deletion
also elevated NF-B activity in intestinal epithelia. VDR
was localized to the surface epithelia of germ-free mice,
but to crypt epithelial cells in conventionalized mice.
VDR expression, distribution, transcriptional activ-
ity, and target genes were regulated by Salmonella
stimulation, independent of 1,25-dihydroxyvitamin
D3. Our study demonstrates that commensal and
pathogenic bacteria directly regulate colonic epithe-
lial VDR expression and location in vivo. VDR nega-
tively regulates bacterial-induced intestinal NF-B
activation and attenuates response to infection.
Therefore, VDR is an important contributor to intes-
tinal homeostasis and host protection from bacterial
invasion and infection. (Am J Pathol 2010, 177:686–697;
DOI: 10.2353/ajpath.2010.090998)
Vitamin D receptor (VDR) is a nuclear receptor1 that
mediates most known functions of 1,25-dihydroxyvitamin
D (1,25[OH]2D3), the hormonal form of vitamin D. VDR
and 1,25(OH)2D3 are involved in calcium homeostasis,
2
electrolyte and blood pressure regulation,3,4 immune re-
sponse,5 and anti-inflammation activity.6,7 Different li-
gand shapes of 1, 25(OH)2D3 act through VDR in differ-
ent cellular locations.8,9 The target genes of the VDR
signal pathway include the enzyme Cyp24 and antimi-
crobial peptides -defensin10,11 and cathelicidin.12
Nuclear factor-B (NF-B) is a family of transcription
factors that play an essential role in innate and adaptive
immune responses. NF-B is active in the nucleus, and
its activity is inhibited by the inhibitor of B (IB).13
VDR physically interacts with NF-B subunit p65 in hu-
man osteoblasts14 and mouse embryonic fibroblast
cells,15 but the functional relevance of this VDR/p65 in-
teraction in regulating intestinal inflammation remains
unclear.
Human intestinal epithelial cells are constitutively ex-
posed to commensal microbiota and pathogenic bacte-
ria. Enteric commensal bacteria play a crucial role in the
pathogenesis of many diseases such as inflammatory
bowel diseases.16–18 and colon cancer.19,20 Several
studies have implicated vitamin D in inflammatory bowel
disease (IBD). Low vitamin D levels have been reported
in patients with IBD.21,22 In animal models, 1,25(OH)2D3
suppressed the development of experimental intestinal
inflammation.23,24 Both local and endocrine synthesis of
1,25(OH)2D3 affect murine colitis
25 and VDR status af-
fects the development of murine colitis.26 VDR mediates
T cell homing to the gut.23 VDR expression is significantly
decreased in IBD patients.22,27 However, the majority of
studies of vitamin D, VDR, and inflammation are focused
on immunoregulation, with little emphasis on assessing
the effects of VDR in intestinal epithelial cells. It is un-
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known how intestinal VDR signaling responds to com-
mensal and pathogenic bacterial stimulation.
In the present study, we hypothesize that Salmonella
typhimurium infection can induce colonic VDR expres-
sion, alter location of VDR in vivo, and stimulate VDR
expression, transcription, and signaling in colonic epithe-
lial cell lines. We found that mice lacking VDR are in a
pre-inflammatory or pro-inflammatory state. Hence, our
current study investigated the effect of VDR ablation on
NF-B activation using a VDR knockout mouse model
infected with pathogenic Salmonella or human commen-
sal Escherichia coli. F18. We also examined intestinal VDR
expression in normal, germ-free (GF), and conventional-
ized wild-type mice. Our data demonstrate that intestinal
VDR is directly involved in suppression of bacteria-in-
duced NF-B activation and that commensal bacterial
colonization affects intestinal epithelial VDR expression
and distribution.
Materials and Methods
Bacterial Strains and Growth Condition
S. typhimurium wild-type ATCC14028, commensal E. coli
F18, and nonpathogenic Salmonella mutant strain PhoPc28
were used in this study. Non-agitated micro-aerophilic bac-
terial cultures were as follows: nonagitated micro-aerophilic
bacterial cultures were prepared by inoculation of 10 ml of
Luria-Bertani broth with 0.01 ml of a stationary phase cul-
ture, followed by overnight incubation (18 hours) at 37°C,
as previously described.29 Bacterial overnight cultures
were concentrated 33-fold in Hanks’ balanced salt solution
(HBSS) supplemented with 10 mmol/L HEPES, pH 7.4.
Streptomycin Pretreated Mouse Model
Animal experiments were performed by using specific-
pathogen-free female C57BL/6 mice (Taconic, Hudson,
NY) that were 6 to 7 weeks old30 and VDR knock out
C57BL/6 mice (Jackson Laboratory, Bar Harbor, Maine)
as previously described.31 The protocol was approved
by the University of Rochester University Committee on
Animal Resources. Water and food were withdrawn 4
hours before oral gavage with 7.5 mg/mouse of strepto-
mycin (100 l of sterile solution or 100 l of sterile water
as control). Afterward, animals were supplied with water
and food. Twenty hours after streptomycin treatment,
water and food were withdrawn again for 4 hours before
the mice were infected with 1  107 colony forming units
(CFU) of S. typhimurium (100-l suspension in HBSS) or
treated with sterile HBSS (control) by oral gavage as
previously described.32 For the mouse survival experi-
ment, 1  108 CFU of S. typhimurium was used.
GF and Conventionalized Mouse Colon
GF mice (129/SvEv) were obtained from the Center for
Gastrointestinal Biology and Disease Gnotobiotic Core
Facility and the National Gnotobiotic Rodent Resource
Center, University of North Carolina, Chapel Hill. Mice
were analyzed at the University of North Carolina National
Gnotobiotic Rodent Resource Center. Sterility of germ-
free mice was documented on a monthly basis by fecal
Gram stains and aerobic and anaerobic cultures of the
feces and bedding. For selected mice, sterility of cecal
contents was documented Gram stain and cultures at the
time of necropsy. Conventionalized mice were originally
GF mice that were infected with a commensal enteric
bacteria by orally swabbing fecal slurries from specific
pathogen-free (SPF) mice, placing fecal slurries on their
food and then housing them in SPF conditions.
Cell Culture
Caco2BBE and HCT116 cells were grown in Dulbecco’s
Modified Eagle Medium (high glucose, 4.5g/L) containing
5% (v/v) fetal bovine serum, 50 g/ml streptomycin, and
50 U/ml penicillin. Monolayers of Caco2BBE cells were
grown on permeable supports (0.33 or 4.67 cm2, 0.4 m
pore. Costar, Cambridge, MA) and used 6 to 14 days
after being plated.
Mouse Embryonic Fibroblasts
Mouse embryonic fibroblasts (MEFs) were isolated from
embryonic day 13.5 embryos generated from VDR/ 
VDR/ mouse breeding as previously described.15
Cells from each embryo were genotyped by PCR using
genomic DNA isolated from the cells. VDR/ and
VDR/ MEFs were used in experiments after more than
15 passages when they had been immortalized.
Bacterial Colonization in Cultured Cells in Vitro
Human colonic epithelial cells were colonized with equal
numbers of the indicated bacteria for 30 minutes, washed
with HBSS, and incubated in Dulbecco’s Modified Eagle
Medium containing gentamicin (500 g/ml) for the times
indicated in our previous studies.29,33 The first 30-minute
incubation allowed bacteria to contact the surface of the
epithelial cells and inject the effectors in the host cells.
After extensive HBSS washing, the extracellular bacteria
were washed away. Incubation with gentamicin inhibited
the growth of bacteria. In this way, we focused on the
effects of the bacterial effectors injected to the host cells.
Immunoblotting
Mouse colonic epithelial cells were collected by scraping
from mouse colon including proximal and distal regions
as previously described.30 Mouse epithelial cells were
lysed in lysis buffer (1% Triton X-100, 150 mmol/L NaCl,
10 mmol/L Tris pH 7.4, 1 mmol/L EDTA, 1 mmol/L EGTA
pH 8.0, 0.2 mmol/L sodium ortho-vanadate, and protease
inhibitor cocktail). MEFs were rinsed twice in ice-cold
HBSS, lysed in protein loading buffer (50 mmol/L Tris, pH
6.8, 100 mmol/L dithiothreitol, 2% SDS, 0.1% bromo-
phenol blue, and 10% glycerol). Immunoblot was per-
formed with primary antibodies: anti-VDR, anti-p65,
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anti-IB (Santa Cruz Biotechnology Inc., Santa Cruz,
CA), anti-phospho-IB, anti-phospho-p65 (ser536)
(Cell Signal, Beverly, MA) or anti--actin (Sigma-Al-
drich, Milwaukee, WI) antibodies and visualized by
enhanced chemiluminescence.15,34
Co-Immunoprecipitation Assay
Cells were rinsed twice in ice-cold HBSS and lysed in
cold immunoprecipitation buffer (1% Triton X-100, 150
mmol/L NaCl, 10 mmol/L Tris pH 7.4, 1 mmol/L EDTA, 1
mmol/L EGTA pH 8.0, 0.2 mmol/L sodium ortho-vana-
date, protease inhibitor cocktail (Boehringer Mannheim).
Samples were immunoprecipitated with the anti-VDR an-
tibody (Santa Cruz) as previously described.15 Blots
were probed with anti-VDR antibody (Transduction Lab-
oratories), stripped, and reprobed with anti-p50 and anti-
p65 antibodies (Santa Cruz Biotechnology, CA) and vi-
sualized by enhanced chemiluminescence.
Nuclear Protein Fraction
Mouse colon epithelial mucosa was washed with HBSS
three times and lysed. The nuclear proteins were ex-
tracted using Nuclear Extract Kit (Active Motif, Carlsbad,
CA). Protein fraction was used for the co-immunoprecipi-
tation assay.
S. typhimurium Invasion of MEFs Monolayers
Infection of MEFs was performed by the method de-
scribed previously.32 Bacterial solution (20 bacteria/
epithelial cell) was added and bacterial invasion was
assessed after 1 hour. Cell-associated bacteria represent
bacteria adhered to and/or internalized into the monolay-
ers were released by incubation with 100 l of 1% Triton
X-100 (Sigma). For cell-associated bacteria, 0.9 ml of
Luria broth was added, mixed, and quantified by plating
on MacConkey agar medium for CFU.
Salmonella Burden in Intestine
Cecum was dissected from mouse, and put into 14 ml
tube with 5 ml sterile PBS, cut into pieces with scissors,
then homogenized adequately using homogenizer (Poly-
tron PT2100, Kinematica, Switzerland). Homogenate was
diluted at 1000 to 10,000 with Luria-Bertani broth. One
hundred l of diluted homogenate was plated out on
MacConkey agar plates and incubated at 37°C over-
night. CFU were quantified.
Histology of Mouse Colon
Mouse colons were harvested, fixed in 10% formalin (pH
7.4), processed, and paraffin embedded. “Swiss rolls”
were prepared as described.35 Sections (5 m) were
stained with H&E. For immunostaining, antigens were re-
trieved by 10-minute boiling in 10 mmol/L citrate (pH 6.0).
The slides were stained with anti-VDR antibody (Santa
Cruz) as previously described.30 Salmonella distribution in
intestine was determined by immunostaining using anti-
Salmonella lipopolysaccharide antibody (Santa Cruz).
Blinded histological inflammatory scores were performed
by a validated scoring system36 by a trained pathologist.
Salmonella-Induced Mouse Interleukin-6
Secretion
Mouse blood samples were collected by cardiac punc-
ture and placed in tubes containing EDTA (10 mg/
ml).37,38 Mouse interleukin (IL)-6 was measured using the
TiterZyme Enzyme Immunometric Assay kits (Assay De-
signs, Inc., Ann Arbor, MI) according to the manufactur-
er’s instructions.
Vitamin D-Responsive Element Transcriptional
Activity
Cells were grown in triplicate and transfected with Cignal
Vitamin D Reporter (luc) Kit (SABiosciences, Frederick,
MD) using Surefect reagent (SABiosciences, Frederick,
MD). The plasmid for the VDR reporter is a mixture of
inducible Vitamin D-responsive firefly luciferase construct
and constitutively expressing Renilla luciferase construct
(40:1). The negative control is a mixture of noninducible
firefly luciferase construct and constitutively expressing
Renilla luciferase construct (40:1). After transfection for
24 hours, cells were colonized with Salmonella for 30
minutes, washed, incubated in Dulbecco’s Modified Ea-
gle Medium with gentamicin (500 g/ml) for 12 hour or 16
hours. Luciferase activity was determined using the Dual
Luciferase Reporter Assay System (Promega) with a TD-
20/20 luminometer (Turner Designs, Sunnyvale, CA).
Quantitative Real-Time PCR Analysis
Total RNA was extracted from epithelial cell monolayers
using TRIzol reagent (Invitrogen, Carlsbad, CA). The re-
verse transcription cDNA reaction products were sub-
jected to quantitative real-time PCR using the MyiQ sin-
gle-color real-time PCR detection system (Bio-Rad) and
iQ SYBR green supermix (Bio-Rad) according to the
manufacturer’s directions.38 All expression levels were
normalized to the -actin levels of the same sample.
Percent expression was calculated as the ratio of the
normalized value of each sample to that of the corre-
sponding untreated control cells. All real-time PCR
reactions were performed in triplicate. All PCR primers
(Table 1) were designed using Lasergene (DNAStar,
Madison, WI).
Statistical Analysis
Data are expressed as mean  SD. Differences between
two samples were analyzed by Student’s t-test. P values
of 0.05 or less were considered significant.
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Results
The Pre-Inflammatory State of the VDR/
Mouse
Because NF-B is a key regulator involved in the synthe-
sis of inflammatory cytokines, we measured the produc-
tion of IL-6, a well-known NF-B target gene, as a read-
out of the biological effect of VDR expression on NF-B
pathway in vivo. The synthesis of IL-6 was compared in
the serum of the VDR/ and VDR/ mice under un-
stimulated (noninfected) and stimulated (pathogenic Sal-
monella infection) conditions. Whereas serum IL-6 in spe-
cific pathogen-free VDR/ mice was undetectable (0.
01pg/ml), it was easily detectable in VDR/ mice (IL-6
200 pg/ml, P  0.0001 vs. wild-type mice) (Figure 1,
VDR/ noninfected control). When the mice were in-
fected with S. typhimurium, serum levels of IL-6 in VDR/
mice (IL-6 1200 pg/ml) was increased from baseline six-
fold compared with VDR/ mice (200 pg/ml, P 
0.0001) (Figure 1A).
VDR Null Mutant Mice Have Worse Outcomes
Following Salmonella-Induced Infection
We used the Salmonella infection model to investigate the
role of VDR in intestinal homeostatic responses to infec-
tion. We compared colitis development in VDR/ and
VDR / mice infected with Salmonella. Figure 1, B–E
show experiments in which VDR/ and VDR/ mice
were infected with S. typhimurium. Cecal inflammation is
the key feature in the Salmonella-colitis mouse model.39
We found that ceca of the VDR/ mice infected with S.
typhimurium looked smaller and more red compared with
the wild-type mice infected with S. typhimurium. The
length of ceca in VDR/ group infected with Salmonella
was significantly decreased comparing to the wild-type
mice (Figure 1B). H&E staining data showed more severe
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Figure 1. VDR-null mutant mice have worse
outcomes with Salmonella-induced infection. A:
Serum IL-6 increased in VDR deficient mice.
Normal mice (VDR/) and VDR-deficient mice
were infected with wild-type S. typhimurium for
six hours. Mouse serum was collected for IL-6
enzyme-linked immunosorbent assay. Data are
presented as the mean  SD from a single ex-
periment assayed in triplicate. *P  0.05. B:
Cecum was dissected out from the indicated
mouse and photographed. Cecum shortening
was found in the mouse intestine with Salmo-
nella infection. C: H&E staining and scores of
the mouse intestine with or without Salmonella
infection. D: Relative body weight change in
mice with or without Salmonella infection. E:
Survival percentage of the VDR/ and VDR/
mice administrated S. typhimurium. wild-type
group n  10, VDR/ group n  12. *P  0.05,
**P  0.01.
Vitamin D Receptor, NF-B, and Bacteria 689
AJP August 2010, Vol. 177, No. 2
intestinal inflammation in VDR/ mice infected with S.
typhimurium compared with the wild-type mice (Figure
1C). Next, the level of intestinal inflammation was quan-
tified histologically in a blinded fashion by a trained pa-
thologist. The inflammation score in the Salmonella-in-
fected VDR/ mice was significantly higher than the
Salmonella-infected VDR/ mice (Figure 1D). Moreover,
the body weight of the Salmonella-infected VDR/ mice
dropped much earlier than the VDR/ mice (Figure 1D).
Ninety percent of VDR/ mice infected with Salmonella
died within 5 days and 100% by 6 days (Figure 1E). In
contrast, VDR/ mice were relatively resistant at Salmo-
nella; with higher survival rates (60%) seen within the
7-day observation period (Figure 1E). Hence, these data
indicate that VDR contributes to host protection against
detrimental outcomes to pathogenic invasive enteric bac-
terial infection.
VDR Expression Protects against Salmonella
Colonization and Mucosal Invasion
We also examined whether VDR expression contribute to
protect cells from Salmonella invasion. Immunofluores-
cence assay showed more Salmonella staining (green) in
the VDR/ mouse intestine. We further counted the num-
bers of Salmonella invading the intestine. VDR/ mice
had increased Salmonella invasion of the intestine,
whereas the VDR/ mouse had significantly fewer Sal-
monella (Figure 2A). Culture of the cecum showed signif-
icantly higher concentrations of Salmonella in the VDR/
mice than in VDR/ mice (Figure 2B). Furthermore, we
used MEFs to investigate the effect of VDR ablation on
Salmonella invasion. We used VDR/ and VDR/
MEFs, as we wanted to compare the difference between
VDR-null and one allele of the Vdr gene. Salmonella inva-
sion was increased in the VDR/ MEFs (Figure 2C).
These in vitro data are consistent with our in vivo findings
(Figure 2, A and B).
Absence of VDR Permits Translocation of
NF-B p65 to the Nucleus
We then assessed the level of NF-B p65 protein, the
most abundant NF-B subunit, in epithelial cells. It is
known that VDR physically binds to p65.14,15 Total p65
was reduced in colonic epithelial cells of noninfected
VDR/ mice (Figure 3, A and B). To examine the possi-
bility that cross-regulation of the VDR and NF-B signal-
ing pathways may occur through physical interaction, we
determined whether VDR can form a complex with NF-B
in vivo. Using a co-immunoprecipitation assay, we found
that the NF-B p65 subunit formed a complex with VDR in
unstimulated wild-type mouse colonic epithelial cells.
VDR deletion totally abolished the VDR/p65 binding in
freshly isolated VDR/ mouse colonic epithelial cells,
whereas there is no interaction of VDR with nonspecific
IgG (Figure 3C). Additionally, we found no apparent in-
teraction of VDR with p50, a NF-B subunit (data not
shown) in wild-type mice indicating that the physical
interaction between VDR and NF-B p65 is specific.
The IP results were also confirmed by cell fraction of
VDR/p65 levels in the cytosolic and nuclear compart-
ments of cells in mouse colon. As shown in Figure 3D,
VDR/p65 binding was found in cytosolic compartments in
normal mouse colon. The VDR/p65 physical interaction
was undetectable in the nuclear fraction of mouse colon
epithelial cells. Thus our data demonstrate a clear phys-
ical interaction between VDR and NF-B in basal colonic
epithelia.
Absence of VDR Permits Translocation of
NF-B p65 to the Nucleus
Because of the lack of VDR, the physical interaction
between VDR and p65 was absent in VDR/ cells. VDR
knockout also reduced the levels of the NF-B inhibitor,
IB, in colonic epithelial cells.40 Consequently, these
alterations combined may led to free p65 and increase
p65 translocation to the nuclei. Immunostaining data








































Figure 2. VDR expression reduces Salmonella invasion in cells. A: Salmo-
nella location (green) in the VDR/ and VDR/ mouse cecum. Normal
mice and VDR deficient mice were infected with wild-type Salmonella
typhimurium for five days. B: Salmonella concentrations in the VDR/ and
VDR mouse ceca. C: Salmonella invasion in infected VDR/ and VDR/
MEFs. MEFs were stimulated with wild-type Salmonella for 30 minutes,
washed, and incubated in fresh Dulbecco’s Modified Eagle Medium for 30
minutes. The mean  SD is from three replicate experiments. **P  0.01.
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mouse colon without any stimulation (Figure 4A). In con-
tract, p65 was located in the cytosol and absent in the
nuclei in the VDR/ mouse colon. Moreover, we exam-
ined the cell fraction of p65 level in the cytosolic and
nuclear compartments of cells in the mouse colon. There
was detectable nuclear p65 in the VDR/ colon,
whereas no p65 was found in the nuclei of the VDR/
mice (Figure 4B). Equal loading of the epithelial cells was
by Villin, the epithelial cell marker. The loading of nuclear
proteins was confirmed by the level of Sp1, a nuclear
protein absent in the cytosol. In the MEFs, the expression
level of p65 in the nuclear extracts was higher in VDR/
cells than in VDR/ cells (Figure 4C). These data are
also consistent with our previous observation in VDR/
MEFs.15 Taken together, our in vivo and in vitro data show
that absence of VDR permits translocation of NF-B p65
to the nucleus.
VDR Expression Negatively Regulates
Transcriptional NF-B Activity
We further hypothesize that the NF-B activity is high in
cells lacking VDR expression. Transcriptional activity of
NF-B is controlled by phosphorylation of p65 at serine
536.41,42 Constitutive phospho-p65 levels were also sig-
nificantly increased in VDR/ MEFs without stimulation
(Figure 4D). We found that VDR/ mouse colonic epi-
thelial cells had significantly elevated phospho-p65, over
2 times of the p-p65 concentrations in VDR/ epithelial
cells (Figure 4E). Overall, absence of VDR led to elevated
levels of phospho-p65 in the fibroblasts and colonic ep-
ithelial cells without any bacterial stimulation.
VDR Distribution in the Normal Mouse Colon
There has been very little information on the VDR distri-
bution in colonic epithelial cells, which are consistently
exposed to the enteric bacteria. We investigated the
distribution of VDR from the proximal colon to the distal
colon in the normal mouse intestine by making a colonic
“Swiss roll” (Figure 5A). We demonstrated less VDR stain-
ing (green) in the distal colon with heavier staining in the
proximal colon. In contrast, 4,6-diamidino-2-phenylindole
staining (blue) is even throughout the colon. Under high
magnification, we identified VDR distributed at the top of
the epithelial cell crypts in the proximal colon. Most of the
enhanced VDR staining is in the cytosol; some of the
staining is in the nuclei (indicated with white arrows in
Figure 5B).
Western blot analysis of VDR levels in colon also con-
firmed the immunostaining observation (Figure 5C). Data
from 4 individual mouse colon samples showed that the
VDR expression is significantly higher in the proximal
colon than that in the distal colon (Figure 5D).
Salmonella Infection Increased the VDR Protein
Expression in Mouse Colon in Vivo
Furthermore, we examined the expression of VDR in
pathogenic bacteria-induced inflammation using normal
mice. Interestingly, we found that the total amount of VDR
protein increased in the colonic epithelium of mice 6
hours after Salmonella infection (Figure 6A). To confirm
that the increased VDR expression is induced specifically
by pathogenic wild-type Salmonella infection, we ga-
vaged the mice with wild-type Salmonella or commensal
E. coli F18. Western blot (Figure 6B) showed that only
wild-type Salmonella was able to increase the expression
of VDR, whereas commensal E. coli F18 colonization did
not change the VDR expression in the mouse colonic
epithelial cells. These results indicate that colonic epithe-
lial responses to specific pathogenic bacteria such as
wild-type Salmonella are determined in part through the
VDR signaling pathway.
VDR Relocation in the Mouse Colon after
Bacterial Infection Colonization
To further examine the distribution of VDR in the mouse
colon with bacterial infection, we used the Salmonella
infection model in normal mice. Histological examination
demonstrates that VDR was located on the surface of
colonic epithelial cells in normal mice without any treat-
ment (Figure 6C control mouse). Pathogenic Salmonella
colonization in mice increased VDR staining at the sur-
face of the crypts, but also induced VDR expression in
the middle and at the bottom of the crypts in mice in-
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Figure 3. The expression of NFB p65 in intestinal epithelial cells in VDR
knockout mice. A: NF-B p65 expression in normal mice and VDR-deficient
mice. Colonic epithelial cells were collected and lysates were immunoblotted
with antibody against NF-B p65. B: Relative NF-B p65 band intensity in
normal and VDR/ mice. Data are presented as the mean  SD from three
repeated experiments. C: VDR physically interacts with NF-B p65 in intes-
tinal epithelial cells in vivo. VDR deletion abolishes this interaction. Mouse
intestinal epithelial cells were collected. Cell lysates were immunoprecipi-
tated with anti-VDR antibody, then the precipitated complex was probed
with anti-p65 antibody by Western blot (W.B. left). Note that the background
level of p65 was detectable in VDR/ cells. An aliquot of the cell lysates was
probed with antibodies against VDR, villin, and -actin to confirm equal
input (right). D: VDR/p65 binding in mouse colon using cell fraction. Mouse
colon epithelial mucosa was lysed and the nuclear proteins were extracted.
Cell fraction was used for co-immunoprecipitation assay using anti-VDR
antibody. N: nuclei; C: cytoplasm. **P  0.01.
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Our data indicate that pathogenic Salmonella infection
changed the location of VDR in colonic epithelial cells.
We also compared GF and conventionalized mice (GF
mice colonized with SPF fecal bacteria) to explore the
effect of bacteria on modulating VDR distribution. Our
data showed that VDR was localized at the top of the
crypts of the GF mouse intestine by immunostaining (Fig-
ure 6D). Bacterial colonization of ex-GF conventionalized
mice for 7 days induced VDR relocation to the middle and
even at the bottom of the crypts. In addition, mono-
association of GF mice with E. coli F18 increased the
epithelial VDR protein expression just like the Salmonella
infection in the SPF mice (Figure 6E).
Salmonella Directly Increased VDR Protein
Expression and VDR Transcriptional Activity
Independent of Vitamin D3
The classical VDR pathway is initiated on 1,25-dihy-
droxyvitamin D3 binding to VDR. Recent studies demon-
strate that VDR was activated through increased protein
expression independent of classical transcriptional reg-
ulation.43–45 Therefore, it is possible that bacteria alone
modulate VDR expression and subsequent activity in the
absence of 1,25-dihydroxyvitamin D3. We cultured hu-
man intestinal epithelial cells in medium with or without
1,25-dihydroxyvitamin D3, then exposed them to Salmo-
nella typhimurium. We found that bacterial colonization of
Caco2 BBE cells for only 1 hour increased VDR expres-
sion in the absence of 1,25-dihydroxyvitamin D3 (Figure
7A). In cells stimulated by 1,25-dihydroxyvitamin D3 for
24 hours, the level of VDR increased, but there was no
additional increase with Salmonella stimulation. We fur-
ther investigated VDR transcription activity under bacte-
rial stimulation in two intestinal epithelial cell lines, Caco2
BBE and HCT116. In cells transfected with the VDR re-
porter plasmid, Salmonella colonization for 12 hours and
16 hours induced the VDR transcriptional activity signifi-
cantly compared with cells without bacteria. The relative
fold increase was compared with cells transfected with
the negative control plasmid (Negative) (Figure 7B). Ad-
ditionally, the expression of VDR target genes Cyp24,
-defensin, and cathelicidin increased significantly after
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Figure 4. The location and activity of NFB p65
in intestinal epithelial cells in VDR knockout
mice. A: NF-B p65 location in colon in normal
mice (VDR/) and VDR/ mice without any
treatment. Arrows indicate the p65 nuclear lo-
cation (green). B: Western blot analysis of p65
levels in cytosolic (C) and nuclear (N) extracts
isolated from VDR/ and VDR/ mouse co-
lons. C: The p65 level in cytosolic and nuclear
extracts isolated from VDR/ and VDR/
MEFs. The nuclear protein Sp1, which is absent
in the cytosolic fraction, serves as a nuclear pro-
tein loading control. D: Higher phospho-p65
level in the VDR/ MEFs without any treat-
ment. *P  0.05. E: Increased phospho-p65 level
in the VDR/ mouse colonic epithelial cells
without any treatment. Relative phospho-p65
band intensity in normal and VDR/ mice is
shown. Villin is used as a marker for epithelial
cells and an internal control. -actin is also used
as an internal control. The mean  SD is from
three repeats. **P  0.01.
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1,25-dihydroxyvitamin D3 in media (Figure 7C). Taken
together, these data indicate that S. typhimurium in-
creased VDR protein expression, VDR transcriptional ac-
tivity and VDR- mediated gene transcription independent
of 1,25-dihydroxyvitamin D3.
Discussion
In the current study, we demonstrate that VDR contrib-
utes to host protection against detrimental outcomes of












































Figure 5. The distribution of VDR in normal mouse colon. A: VDR distribution in the “Swiss roll” made with the SPF mouse colon. Arrow indicates the direction
of the proximal and distal colon. B: Higher magnification of VDR distribution in the normal mouse proximal colon. White arrow indicates the nuclear staining
of VDR at the top of colonic crypts. C: VDR protein expression in the proximal and distal colon determined by Western blot. DC: distal colon; PC: proximal colon.
























































































Figure 6. The expression and location of VDR
protein in mouse intestinal epithelial cells in-
fected with or without bacteria. A: Total VDR
protein in mouse colonic epithelial cells in-
creased after infection with pathogenic Salmo-
nella typhimurium for six hours. B: Normal mice
were gavaged without () or with either wild-
type Salmonella typhimurium or E. coli F18 for
six hours. Colonic epithelial cell lysates were
immunoblotted with antibodies against VDR or
-actin. Data are from a single experiment and
are representative of three separate mouse cells.
*P  0.05. C: Relocation of VDR after Salmonella
for six hours. D: VDR distribution in germ-free
and conventionalized mouse intestine seven
days after colonization with SPF slurries. E: Total
VDR protein in mouse colonic epithelial cells
increased after GF mice mono-associated with
E.coli F18 for six days. **P  0.01.
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wild-type mouse with VDR expression in the intestine,
VDR is able to reduce Salmonella invasion comparing to
the VDR/ cells. Therefore, there is less bacterial bur-
den in the wild-type intestine. Moreover, VDR expression
increases after Salmonella infection in intestine. VDR
plays a role as a negative regulator of the NF-B activity
and modulates inflammatory responses of the host, thus
allowing mice to survive the enteric bacterial infection
(Figure 8A). In contract, VDR/ cells have more Salmo-
nella invasion in the intestine. Mice lacking VDR have a
pro-inflammatory state due to intrinsically high NF-B
activity. VDR deletion leads to more aggressive gross
and histological colonic injury, increases serum IL-6 lev-
els as a marker of systemic inflammation, and enhances
mortality after Salmonella infection (Figure 8B). Hence,
VDR is an important contributor to host protection and
intestinal homeostasis.
We postulate that increased NF-B activity in VDR/
intestinal cells is a consequence of the absence of VDR,
which leads to free p65 and elevated phospho-p65, in
part due to the reduction in IB.40 Consistent with these
findings, the induction of serum IL-6 by pathogenic bac-
terial infection was much more robust in VDR/ than in
VDR/ mice. Interestingly, basal IL-6 serum levels in
noninfected VDR/ mice were comparable to those of
Salmonella infected VDR/ mice. This is consistent
with our demonstration that NF-B activity is increased
in MEFs lacking the vitamin D receptor, leading to a
pre-inflammatory or pro-inflammatory state.15 Take to-
gether; our in vitro and in vivo data suggest that VDR
negatively regulates NF-B activity and suppresses
inflammatory responses to a common invasive enteric
bacterial pathogen.
We demonstrate intracellular complexes of VDR and
p65 in freshly isolated colonic epithelial cells. Likewise,
VDR physically interacts with NF-B p65 in osteoblasts14
and fibroblasts15. In tubular cells, VDR/p65 formed a
complex, thus inhibiting the ability of p65 to transactivate
gene transcription.46 In the present study, we show that
VDR is able to negatively modulate NF-B activity
through physical binding with NF-B p65, decreasing
translocation of p65 in the nucleus, and reducing p65
phosphorylation. Intestinal VDR concentrations are in-
creased by enteric Salmonella infection and are directly
involved in the regulation of the NF-B pathway in intes-
tinal epithelial inflammation in vivo. Consistent with a host
protective role of intestinal VDR during intestinal infection,
VDR null mutant mice have worse outcomes following
Salmonella-induced infection.
Our study also demonstrates that enteric bacterial in-
fection directly increases VDR protein expression and
distribution in the colon and that commensal enteric bac-
teria also influence VDR distribution in epithelial cells. In
the normal mouse colon, VDR locates to differentiated
colonic epithelial cells at the top of crypts. Pathogenic
Salmonella infection increases VDR expression and
changes VDR distribution in mouse colonic epithelial
cells in vivo to cells lower in the crypt. VDR was localized





















































































































































Figure 7. Salmonella directly increases VDR expression and transcriptional
activity in human intestinal epithelial cells. A: Salmonella directly increases
VDR protein expression in human intestinal epithelial CaCo2 BBE cells in the
absence of 1,25-dihydroxyvitamin D3 (). 1,25-Dihydroxyvitamin D3 (20
nmol/L) stimulated VDR protein was measured by Western blot. B: Salmo-
nella colonization increased the VDR transcription activity in human epithe-
lial cells. The cells were transfected with Cignal Vitamin D Reporter (luc) Kit.
After transfection for 24 hours, cells were colonized with Salmonella for
indicated time and lysed, and luciferase activity was determined. Firefly
luciferase activity was normalized to Renilla luciferase activity, and the
activity was expressed as relative luminescence units. C: Salmonella coloni-
zation increased the mRNA level of the VDR target genes in human epithelial
cells. *P  0.05; **P  0.001. Data are from a single experiment and are
representative of two to three separate experiments.
Bacteria
Inflammation









Figure 8. Working model of VDR in regulation of bacterial invasion, NF-B
activity, host protection, and intestinal homeostasis.
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sal bacterial colonization of GF mice (conventionaliza-
tion) induced VDR relocation in the colon and similar to
cecum (data not shown) that seen with pathogenic Sal-
monella infection in conventional mice. The small intestine
contains relatively few bacteria compared with the colon;
therefore, bacterial colonization in GF mice did not
change the VDR distribution in small intestine (data not
shown). VDR exerts multiple effects, differentiation,9
growth inhibitory31,47 and anti-inflammatory actions.7,14
The relocation of VDR in intestine may relate to transient
activation of NFB and other signaling pathways by col-
onization of the GF colon by commensal bacteria48 or
infection in specific-pathogen-free mice49 or possibly by
replacement of the infected epithelial cells and host de-
fense against the Salmonella-induced damage.
Using normal mice, we also identified a gradient for
distribution of VDR from the proximal colon to the distal
colon. In the normal proximal colon, bacterial fermenta-
tion is very intense with high production of short-chain
fatty acids, an acid environment (pH 5 to 6), and rapid
bacterial growth.50 By contrast, the distal colon has less
substrate availability, neutral pH and slow bacterial
growth.50 Interestingly, we found that in the proximal
colon where the bacterial growth and metabolism is high,
VDR expression is enhanced, whereas in the distal colon
with less commensal bacterial growth, less VDR expres-
sion was detected. Our data on the distribution of VDR
expression in the gut are correlated with bacterial den-
sity. VDR plays a critical role in protecting the colon from
injury and maintaining intestinal integrity.26,51 Previous
studies indicated that bacterial products, such as bu-
tyrate, regulate VDR expression.52–56 Therefore, bacterial
growth and metabolic products may contribute to the
gradient distribution of VDR in the colonic epithelium in
normal mice and be responsible for redistribution of VDR
to the base and middle of colonic epithelial crypts after
colonization of GF mice with complex enteric commensal
microbiota.
Toll-like receptors are key contributors to bacterial-
induced inflammation and commensal bacteria- driven
epithelial homeostasis.57–59 Recent studies show that ac-
tivation of toll-like receptor-2 on human macrophages
up-regulated the expression of VDR and induced the
human antimicrobial peptide CAMP and killing of intra-
cellular Mycobacterium tuberculosis.6 It is known that the
CAMP gene is strongly up-regulated in myeloid cells by
1,25(OH)2D3.
12 This process was dependent on both the
endogenous production and action of 1,25(OH)2D3
through the VDR. It will be interesting to investigate the
influence of intestinal toll-like receptor signaling on VDR
expression in a future study.
Our data indicate that VDR expression, location, tran-
scriptional activity, and target gene expression are reg-
ulated by intestinal bacteria, which may be independent
of 1,25-dihydroxyvitamin D3. Classically, VDR is consid-
ered to be a ligand-activated transcription factor. VDR
binds to the vitamin D-response element in the target
gene promoter to regulate gene transcription.60 Several
studies demonstrate that VDR signaling can be activated
independent of 1,25-dihydroxyvitamin D3.34,45,61 Our
study suggested that bacteria directly activate VDR sig-
naling by increasing protein level of VDR. We have not
addressed this issue in vivo, but did show 1,25-dihy-
droxyvitamin D3 independent induction of VDR by Sal-
monella in colonic cell lines in vitro.
In summary, we demonstrate that an invasive enteric
pathogen, S. typhimurium, can induce colonic VDR ex-
pression and location in vivo, and stimulate VDR expres-
sion, transcription, and signaling in colonic epithelial cell
lines and MEFs. Our current study also highlights the
importance of VDR in negatively regulating bacterial-
stimulated NF-B activity in intestine. The presence of
VDR in various tissues along with its ability to exert dif-
ferentiation,9 growth inhibitory31,47 and anti-inflammatory
actions,7,14 set the stage for therapeutic exploitation of
VDR ligands for the treatment of various intestinal inflam-
matory conditions and cancers.62 Our results and other
investigators’ studies demonstrate that VDR has multiple
critical functions in regulating response to enteric inva-
sive pathogen, intestinal homeostasis,26,51 tight junction
structure,26 bacterial infection, and commensal bacterial
colonization. Given the crucial role of enteric microbiota
in the pathogenesis of IBD16–18,57 and the therapeutic
and pharmacological potential of probiotics in the treat-
ment of inflammatory bowl disease,63,64 understanding
how pathogenic bacteria and probiotics regulate the VDR
pathway may facilitate the development of targeted inter-
ventions to control intestinal inflammation.
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